Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma

G. Riethmüller(Ludwig-Maximilians-Universität München), Rudolf Gruber(Ludwig-Maximilians-Universität München), E. Schneider-Gädicke(Ludwig-Maximilians-Universität München), Günter Schlimok, Jens Witte, R. Raab(Medizinische Hochschule Hannover), R. Pichlmayr(Medizinische Hochschule Hannover), H. Pichlmaier(Chirurgische Universitätsklinik Heidelberg), Wolff Schmiegel(Eppendorf (Germany)), Peter Buggisch(Eppendorf (Germany)), K. Höffken, H. Hirche, R. Pichimayr, Peter Buggisch(Eppendorf (Germany)), Jens Witte, German Cancer Aid –A Study Group
The Lancet
May 1, 1994
10.1016/s0140-6736(94)92398-1
Cited by 638

Abstract

Related Papers

Continuous cultures of fused cells secreting antibody of predefined specificity
Georges Köhler, César Milstein|Nature|1975|17.1k
Effective Surgical Adjuvant Therapy for High-Risk Rectal Carcinoma
James E. Krook, C G Moertel, Leonard L. Gunderson et al.|New England Journal of Medicine|1991|1.9k
Colorectal carcinoma antigens detected by hybridoma antibodies
Hilary Koprowski, Zenon Steplewski, Kenneth F. Mitchell et al.|Somatic Cell and Molecular Genetics|1979|1.4k
A New Design for Randomized Clinical Trials
Marvin Zelen|New England Journal of Medicine|1979|1.1k
Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies.
Meenhard Herlyn, Zenon Steplewski, Dorothee Herlyn et al.|Proceedings of the National Academy of Sciences|1979|664